Item Type | Name |
Concept
|
Antineoplastic Combined Chemotherapy Protocols
|
Concept
|
Cat Diseases
|
Concept
|
Gastrointestinal Diseases
|
Concept
|
Cardiovascular Diseases
|
Concept
|
Drug Therapy
|
Concept
|
Drug Therapy, Combination
|
Concept
|
Kidney Diseases
|
Concept
|
Hematopoietic Stem Cells
|
Concept
|
Intestinal Diseases
|
Concept
|
Hodgkin Disease
|
Concept
|
Rectal Diseases
|
Concept
|
Recurrence
|
Concept
|
Stem Cells
|
Concept
|
Tumor Stem Cell Assay
|
Concept
|
Urologic Diseases
|
Concept
|
Uveal Diseases
|
Concept
|
Hematopoietic Stem Cell Transplantation
|
Concept
|
Vascular Diseases
|
Concept
|
Neoplasm Recurrence, Local
|
Concept
|
Disease Progression
|
Concept
|
Paget Disease, Extramammary
|
Concept
|
Peripheral Blood Stem Cell Transplantation
|
Concept
|
Endemic Diseases
|
Concept
|
Genetic Diseases, Inborn
|
Concept
|
Pleural Diseases
|
Concept
|
Chemotherapy, Adjuvant
|
Concept
|
Induction Chemotherapy
|
Concept
|
Male Urogenital Diseases
|
Concept
|
Disease Models, Animal
|
Concept
|
Graft Occlusion, Vascular
|
Concept
|
Neoplastic Stem Cells
|
Concept
|
Disease-Free Survival
|
Concept
|
Genetic Predisposition to Disease
|
Academic Article
|
Treatment and prognosis of orbital non-Hodgkin's lymphomas.
|
Academic Article
|
Re-irradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer: a potentially curable disease.
|
Academic Article
|
Continuous infusion paclitaxel, 5-fluorouracil, and hydroxyurea with concomitant radiotherapy in patients with advanced or recurrent head and neck cancer.
|
Academic Article
|
Late rectal sequelae following definitive radiation therapy for carcinoma of the uterine cervix: a dosimetric analysis.
|
Academic Article
|
Favorable long-term survival following induction chemotherapy with cisplatin, fluorouracil, and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer.
|
Academic Article
|
Head and neck cancer.
|
Academic Article
|
Cisplatin, fluorouracil, and leucovorin augmented by interferon alfa-2b in head and neck cancer: a clinical and pharmacologic analysis.
|
Academic Article
|
Angiogenesis as a predictor of long-term survival for patients with node-negative breast cancer.
|
Academic Article
|
Pharmacodynamics of fluorouracil-based induction chemotherapy in advanced head and neck cancer.
|
Academic Article
|
Perspectives on combination chemotherapy with concomitant radiotherapy for poor-prognosis head and neck cancer.
|
Academic Article
|
Breast preservation in stage I and II carcinoma of the breast. The University of Chicago experience.
|
Academic Article
|
Race and clinical outcome in breast cancer in a series with long-term follow-up evaluation.
|
Academic Article
|
Radiation therapy with concomitant hydroxyurea and fluorouracil in stage II and III head and neck cancer.
|
Academic Article
|
Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, and hydroxyurea with granulocyte colony-stimulating factor support for patients with poor-prognosis cancer of the head and neck.
|
Academic Article
|
Modulation of apoptotic response of a radiation-resistant human carcinoma by Pseudomonas exotoxin-chimeric protein.
|
Academic Article
|
Induction chemotherapy followed by concurrent chemoradiation for advanced head and neck cancer: improved disease control and survival.
|
Academic Article
|
Neoadjuvant PFL augmented by methotrexate and piritrexim followed by concomitant chemoradiotherapy for advanced head and neck cancer: a feasible and active approach.
|
Academic Article
|
Virally directed cytosine deaminase/5-fluorocytosine gene therapy enhances radiation response in human cancer xenografts.
|
Academic Article
|
Decreasing the apoptotic threshold of tumor cells through protein kinase C inhibition and sphingomyelinase activation increases tumor killing by ionizing radiation.
|
Academic Article
|
Thymidylate synthase expression and response to neoadjuvant chemotherapy in patients with advanced head and neck cancer.
|
Academic Article
|
Strategies for enhancing viral-based gene therapy using ionizing radiation.
|
Academic Article
|
Potentiation of the antitumor effect of ionizing radiation by brief concomitant exposures to angiostatin.
|
Academic Article
|
Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation.
|
Academic Article
|
Nasopharyngeal carcinoma.
|
Academic Article
|
Multimodality therapy in advanced paranasal sinus carcinoma: superior long-term results.
|
Academic Article
|
Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer.
|
Academic Article
|
Concomitant chemoradiotherapy with cisplatin, 5-fluorouracil and hydroxyurea in poor-prognosis head and neck cancer.
|
Academic Article
|
Prognostic indicators in node-negative early stage breast cancer.
|
Academic Article
|
Function for p300 and not CBP in the apoptotic response to DNA damage.
|
Academic Article
|
Paclitaxel, 5-fluorouracil, hydroxyurea, and concomitant radiation therapy for poor-prognosis head and neck cancer.
|
Academic Article
|
5-Fluorouracil, leucovorin, hydroxyurea, and escalating doses of continuous-infusion cisplatin with concomitant radiotherapy: a clinical and pharmacologic study.
|
Academic Article
|
Hydroxyurea with concomitant radiotherapy for locally advanced head and neck cancer.
|
Academic Article
|
cis-Diamminedichloroplatinum(II) induces c-jun expression in human myeloid leukemia cells: potential involvement of a protein kinase C-dependent signaling pathway.
|
Academic Article
|
Combined gene therapy and ionizing radiation is a novel approach to treat human esophageal adenocarcinoma.
|
Academic Article
|
Equivalent racial outcome after conformal radiotherapy for prostate cancer: a single departmental experience.
|
Academic Article
|
Clinical protocol. An open-label, phase I, dose-escalation study of tumor necrosis factor-alpha (TNFerade Biologic) gene transfer with radiation therapy for locally advanced, recurrent, or metastatic solid tumors.
|
Academic Article
|
Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer.
|
Academic Article
|
The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin.
|
Academic Article
|
Sequential induction chemotherapy and concomitant chemoradiotherapy in the management of locoregionally advanced laryngeal cancer.
|
Academic Article
|
Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for locally advanced head and neck cancer: a clinical and pharmacologic analysis.
|
Academic Article
|
Palliative radiotherapy.
|
Academic Article
|
Evolution of toxicity after conformal radiotherapy for prostate cancer.
|
Academic Article
|
Survival and analysis of failure following hydroxyurea, 5-fluorouracil and concomitant radiation therapy in poor prognosis head and neck cancer.
|
Academic Article
|
Angiostatin potentiates cyclophosphamide treatment of metastatic disease.
|
Academic Article
|
Transcriptional control of viral gene therapy by cisplatin.
|
Academic Article
|
Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer.
|
Academic Article
|
Control of gene therapy by MDR1 and EGR1 promoter sequences in transcriptional targeting by chemotherapy (Review).
|
Academic Article
|
Prognostic factors in advanced head and neck cancer patients undergoing multimodality therapy.
|
Academic Article
|
Influence of radioimmunoscintigraphy on postprostatectomy radiotherapy treatment decision making.
|
Academic Article
|
Radiotherapy with concomitant chemotherapy for head and neck cancer.
|
Academic Article
|
Prevention of restenosis by a herpes simplex virus mutant capable of controlled long-term expression in vascular tissue in vivo.
|
Academic Article
|
Curative radiotherapy following chemotherapy for invasive bladder carcinoma (a preliminary report).
|
Academic Article
|
Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy.
|
Academic Article
|
Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal cancer.
|
Academic Article
|
Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation.
|
Academic Article
|
Radiation's outer limits.
|
Academic Article
|
Possible applications of biotechnology to radiotherapy.
|
Academic Article
|
Multicenter randomized Phase II study of paclitaxel (1-hour infusion), fluorouracil, hydroxyurea, and concomitant twice daily radiation with or without erythropoietin for advanced head and neck cancer.
|
Academic Article
|
Sustained inhibition of experimental neointimal hyperplasia with a genetically modified herpes simplex virus.
|
Academic Article
|
Role of external beam radiotherapy with low-dose-rate brachytherapy in treatment of prostate cancer.
|
Academic Article
|
Concomitant chemoradiotherapy: rationale and clinical experience in patients with solid tumors.
|
Academic Article
|
Forphenicinol enhances the antitumor effects of cyclophosphamide in a model of squamous cell carcinoma.
|
Academic Article
|
Cisplatin and fluorouracil chemotherapy does not yield long-term benefit in locally advanced head and neck cancer: results from a single institution.
|
Academic Article
|
Intensity-modulated radiation therapy in advanced head and neck patients treated with intensive chemoradiotherapy: preliminary experience and future directions.
|
Academic Article
|
Establishment of a syngeneic model of hepatic colorectal oligometastases.
|
Academic Article
|
Is pelvic irradiation necessary in stage III1A Hodgkin's disease?
|
Academic Article
|
More on cetuximab in head and neck cancer.
|
Academic Article
|
An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer.
|
Academic Article
|
Multidisciplinary treatment for childhood sarcoma.
|
Academic Article
|
Analysis of further disease progression in metastatic non-small cell lung cancer: implications for locoregional treatment.
|
Academic Article
|
Initial adjuvant therapy in advanced squamous cell carcinoma of the head and neck employing weekly high dose methotrexate with leucovorin rescue.
|
Academic Article
|
Variation in radiation sensitivity during the cell cycle of two human squamous cell carcinomas.
|
Academic Article
|
Initial adjuvant weekly high dose methotrexate with leucovorin rescue in advanced squamous carcinoma of the head and neck.
|
Academic Article
|
MUC1-induced transcriptional programs associated with tumorigenesis predict outcome in breast and lung cancer.
|
Academic Article
|
Phase I study of bevacizumab added to fluorouracil- and hydroxyurea-based concomitant chemoradiotherapy for poor-prognosis head and neck cancer.
|
Academic Article
|
Radioimmunoscintigraphy for postprostatectomy radiotherapy: analysis of toxicity and biochemical control.
|
Academic Article
|
An initial report of a radiation dose-escalation trial in patients with one to five sites of metastatic disease.
|
Academic Article
|
Chromosomal sensitivity of lymphocytes from individuals with therapy-related acute nonlymphocytic leukemia.
|
Academic Article
|
Predefinitive and postdefinitive chemotherapy for locally advanced squamous carcinoma of the head and neck.
|
Academic Article
|
Oral PEG 15-20 protects the intestine against radiation: role of lipid rafts.
|
Academic Article
|
Neoadjuvant vindesine, etoposide, and cisplatin for locally advanced non-small cell lung cancer. Final report of a phase 2 study.
|
Academic Article
|
Importance of local control in an era of systemic therapy.
|
Academic Article
|
Dose-escalated radiation therapy for intermediate-risk prostate cancer: patient selection for androgen deprivation therapy using percentage of positive cores.
|
Academic Article
|
An analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamous-cell carcinoma of the head and neck.
|
Academic Article
|
Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment.
|
Academic Article
|
Breast conserving surgery and definitive irradiation for early stage breast cancer.
|
Academic Article
|
Statin use and risk of prostate cancer recurrence in men treated with radiation therapy.
|
Academic Article
|
A randomized study comparing two regimens of neoadjuvant and adjuvant chemotherapy in multimodal therapy for locally advanced head and neck cancer.
|
Academic Article
|
The efficacy of radiotherapy relies upon induction of type i interferon-dependent innate and adaptive immunity.
|
Academic Article
|
Salvage radiotherapy after postprostatectomy biochemical failure: does pretreatment radioimmunoscintigraphy help select patients with locally confined disease?
|
Academic Article
|
Radiation therapy in the treatment of cervical cancer: the University of Chicago/Michael Reese Hospital experience.
|
Academic Article
|
Adjuvant radiotherapy for resected pancreatic cancer: a lack of benefit or a lack of adequate trials?
|
Academic Article
|
MUC1-induced alterations in a lipid metabolic gene network predict response of human breast cancers to tamoxifen treatment.
|
Academic Article
|
Radiation therapy for pathologic stage III Hodgkin's disease with and without chemotherapy.
|
Academic Article
|
Cell biological effects of total body irradiation on growth and differentiation of acute myelogenous leukemia cells compared to normal bone marrow.
|
Academic Article
|
Vascular events in patients receiving high-dose infusional 5-fluorouracil-based chemotherapy: the University of Chicago experience.
|
Academic Article
|
A randomized study of inpatient versus outpatient continuous intravenous infusion chemotherapy: psychosocial aspects.
|
Academic Article
|
Progression of cancer from indolent to aggressive despite antigen retention and increased expression of interferon-gamma inducible genes.
|
Academic Article
|
Issues of controversy in radiation therapy and combined modality approaches to Hodgkin's disease.
|
Academic Article
|
Concomitant hydroxyurea, 5-fluorouracil, and radiation therapy for recurrent head and neck cancer: early results.
|
Academic Article
|
Radioresistant tumor cells are present in head and neck carcinomas that recur after radiotherapy.
|
Academic Article
|
The syndrome of inappropriate antidiuretic hormone secretion associated with induction chemotherapy for squamous cell carcinoma of the head and neck.
|
Academic Article
|
Magnetic resonance imaging identifies multifocal and multicentric disease in breast cancer patients who are eligible for partial breast irradiation.
|
Academic Article
|
Cisplatin, fluorouracil, and high-dose leucovorin for recurrent or metastatic head and neck cancer.
|
Academic Article
|
Extended mantle radiation therapy for pathologic stage I and II Hodgkin's disease.
|
Academic Article
|
Prognostic factors in patients with subdiaphragmatic Hodgkin's disease.
|
Academic Article
|
Treatment complications after sequential combination chemotherapy and radiotherapy with or without surgery in previously untreated squamous cell carcinoma of the head and neck.
|
Academic Article
|
The influence of initial pathologic stage on the survival of patients who relapse from Hodgkin's disease.
|
Academic Article
|
Intensified concomitant chemoradiotherapy with and without filgrastim for poor-prognosis head and neck cancer.
|
Academic Article
|
Patterns of failure following high-dose chemotherapy and autologous bone marrow transplantation with involved field radiotherapy for relapsed/refractory Hodgkin's disease.
|
Academic Article
|
Efficacy and safety of treating T4 oral cavity tumors with primary chemoradiotherapy.
|
Academic Article
|
Predictors of competing mortality in advanced head and neck cancer.
|
Academic Article
|
A randomized study of inpatient versus outpatient continuous infusion chemotherapy for patients with locally advanced head and neck cancer.
|
Academic Article
|
An aggressive approach to marginally resectable lung cancer.
|
Academic Article
|
Long-term culture of human granulocytes and granulocyte progenitor cells.
|
Academic Article
|
Combined modality treatment of head and neck cancer with cisplatin, bleomycin, methotrexate-leucovorin chemotherapy.
|
Academic Article
|
Neoadjuvant and adjuvant methotrexate, cisplatin, and fluorouracil in multimodal therapy of head and neck cancer.
|
Academic Article
|
Management of stage I and II Hodgkin's disease.
|
Academic Article
|
Substaging of stage III Hodgkin's disease.
|
Academic Article
|
Treatment of advanced squamous cell carcinoma of the head and neck with cisplatin, bleomycin, and methotrexate (PBM).
|
Academic Article
|
Incidence of hypothyroidism following multimodality treatment for advanced squamous cell cancer of the head and neck.
|
Academic Article
|
Increased therapeutic index using moderate dose methotrexate and leucovorin twice weekly vs. weekly high dose methotrexate-leucovorin in patients with advanced squamous carcinoma of the head and neck: a safe new effective regimen.
|
Academic Article
|
Treatment of perineural metastasis from squamous carcinoma of the skin with aggressive combination chemotherapy and irradiation.
|
Academic Article
|
Patterns of failure following total body irradiation and bone marrow transplantation with or without a radiotherapy boost for advanced neuroblastoma.
|
Academic Article
|
Hydroxyurea, fluorouracil, and concomitant radiotherapy in poor-prognosis head and neck cancer: a phase I-II study.
|
Academic Article
|
Radiation therapy in the management of patients with mesothelioma.
|
Academic Article
|
The role of chemotherapy for advanced carcinoma of the supraglottic and glottic larynx.
|
Academic Article
|
Toxicity of aggressive multimodality therapy including cisplatinum, bleomycin and methotrexate with radiation and/or surgery for advanced head and neck cancer.
|
Academic Article
|
Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease.
|
Academic Article
|
Improved survival for patients with advanced carcinoma of the head and neck treated with methotrexate-leucovorin prior to definitive radiotherapy or surgery.
|
Academic Article
|
Hypofractionated image-guided radiation therapy for patients with limited volume metastatic non-small cell lung cancer.
|
Academic Article
|
The role of paclitaxel in the treatment of head and neck cancer.
|
Academic Article
|
Hydroxyurea with continuous infusion paclitaxel, 5-fluorouracil, and concomitant radiotherapy for poor-prognosis head and neck cancer.
|
Academic Article
|
Conservative surgery and adjuvant radiation therapy in the management of adult soft tissue sarcoma of the extremities: clinical and radiobiological results.
|
Academic Article
|
Combination hormonal, chemotherapy and radiotherapy in vitro: implications for therapy in vivo.
|
Academic Article
|
The role of radiation therapy in the treatment of soft tissue sarcomas of childhood.
|
Academic Article
|
Photon neutron mixed-beam radiotherapy of locally advanced prostate cancer.
|
Academic Article
|
Advanced squamous carcinoma of the head and neck. A preliminary report of neoadjuvant chemotherapy with cisplatin, bleomycin, and methotrexate.
|
Academic Article
|
Chemotherapy for advanced carcinoma of the head and neck. A clinical update.
|
Academic Article
|
Limited penetration of methotrexate into human osteosarcoma spheroids as a proposed model for solid tumor resistance to adjuvant chemotherapy.
|
Academic Article
|
X-ray sensitivity of fifty-three human diploid fibroblast cell strains from patients with characterized genetic disorders.
|
Academic Article
|
Concomitant chemoradiotherapy, neutron boost, and adjuvant chemotherapy for anaplastic astrocytoma and glioblastoma multiforme.
|
Academic Article
|
Predictors of competing mortality in early breast cancer.
|
Academic Article
|
Methotrexate, vinblastine, doxorubicin and cisplatin followed by radiotherapy or surgery for muscle invasive bladder cancer: the University of Chicago experience.
|
Academic Article
|
Chemotherapy of advanced salivary gland neoplasms.
|
Academic Article
|
Natural history of node-positive breast cancer: the curability of small cancers with a limited number of positive nodes.
|
Academic Article
|
Natural history of node-negative breast cancer: a study of 826 patients with long-term follow-up.
|
Academic Article
|
Combined modality therapy of head and neck cancer.
|
Academic Article
|
Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer.
|
Academic Article
|
Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced oropharyngeal cancer.
|
Academic Article
|
Network modeling identifies molecular functions targeted by miR-204 to suppress head and neck tumor metastasis.
|
Academic Article
|
Outcomes in black patients with early breast cancer treated with breast conservation therapy.
|
Academic Article
|
Cisplatin, 5-fluorouracil, and high-dose oral leucovorin for advanced head and neck cancer.
|
Academic Article
|
MicroRNA expression characterizes oligometastasis(es).
|
Academic Article
|
Sequential administration of methotrexate, cisplatin, and 5-fluorouracil in multimodal therapy for locally advanced head and neck cancer.
|
Academic Article
|
Pathogenesis of pleural effusion in carcinoma of the breast.
|
Academic Article
|
The evolution of combination therapy of genitourinary rhabdomyosarcoma in children: a preliminary report.
|
Academic Article
|
The role of post-operative radiation therapy in the treatment of malignant tumors of the parotid gland.
|
Academic Article
|
The role of postoperative irradiation in carcinoma of the breast.
|
Academic Article
|
Role of chemotherapy in the multidisciplinary approach to advanced head and neck cancer: potentials and problems.
|
Academic Article
|
The treatment of stage III nonsmall cell lung cancer using high dose conformal radiotherapy.
|
Academic Article
|
Measurement of weekly prostate specific antigen levels in patients receiving pelvic radiotherapy for nonprostatic malignancies.
|
Academic Article
|
Patterns of failure of complete responders following high-dose chemotherapy and autologous bone marrow transplantation for metastatic breast cancer: implications for the use of adjuvant radiation therapy.
|
Academic Article
|
Time-dose relationship for local tumor control following alternate week concomitant radiation and chemotherapy of advanced head and neck cancer.
|
Academic Article
|
Locoregionally advanced paranasal sinus carcinoma. Favorable survival with multimodality therapy.
|
Academic Article
|
Uveal malignant melanoma in three generations of the same family.
|
Academic Article
|
Diagnostic imaging of the feline lower urinary tract.
|
Academic Article
|
Bilateral malignant choroidal melanomas.
|
Academic Article
|
A phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFerade? Biologic) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer undergoing reirradiation.
|
Academic Article
|
Radiation-induced equilibrium is a balance between tumor cell proliferation and T cell-mediated killing.
|
Academic Article
|
Stereotactic body radiation therapy for curative treatment of adrenal metastases.
|
Academic Article
|
Oligo- and polymetastatic progression in lung metastasis(es) patients is associated with specific microRNAs.
|
Academic Article
|
Combination of linear accelerator-based intensity-modulated total marrow irradiation and myeloablative fludarabine/busulfan: a phase I study.
|
Academic Article
|
DNA repair biomarkers XPF and phospho-MAPKAP kinase 2 correlate with clinical outcome in advanced head and neck cancer.
|
Academic Article
|
Towards a molecular basis of oligometastatic disease: potential role of micro-RNAs.
|
Academic Article
|
Comparison of carboplatin-paclitaxel to docetaxel-cisplatin-5-flurouracil induction chemotherapy followed by concurrent chemoradiation for locally advanced head and neck cancer.
|
Academic Article
|
Effect of postradiotherapy neck dissection on nonregional disease sites.
|
Academic Article
|
Feasibility and toxicity of hypofractionated image guided radiation therapy for large volume limited metastatic disease.
|
Academic Article
|
DNA repair pathway gene expression score correlates with repair proficiency and tumor sensitivity to chemotherapy.
|
Academic Article
|
Racial parities in outcomes after radiotherapy for head and neck cancer.
|
Academic Article
|
Optimizing management of colorectal hepatic metastases: now and in the future.
|
Academic Article
|
Defining the Benefit of Adjuvant Therapy Following Resection for Intrahepatic Cholangiocarcinoma.
|
Academic Article
|
Imaging of tumor clones with differential liver colonization.
|
Academic Article
|
Nanomedicine for Combination Therapy of Cancer.
|
Academic Article
|
MUC1-C activates the TAK1 inflammatory pathway in colon cancer.
|
Academic Article
|
Role of GADD45a in murine models of radiation- and bleomycin-induced lung injury.
|
Academic Article
|
Patterns of Failure After Radical Cystectomy for pT3-4 Bladder Cancer: Implications for Adjuvant Radiation Therapy.
|
Academic Article
|
Autologous Bone Marrow Transplantation Followed by Involved Field Radiotherapy in Patients with Relapsed or Refractory Hodgkin's Disease.
|
Academic Article
|
Core-shell nanoscale coordination polymers combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapy.
|
Academic Article
|
Advanced Animal Model of Colorectal Metastasis in Liver: Imaging Techniques and Properties of Metastatic Clones.
|
Academic Article
|
Transfer of Allogeneic CD4+ T Cells Rescues CD8+ T Cells in Anti-PD-L1-Resistant Tumors Leading to Tumor Eradication.
|
Academic Article
|
CD95/Fas Increases Stemness in Cancer Cells by Inducing a STAT1-Dependent Type I Interferon Response.
|
Academic Article
|
Low Recombination Proficiency Score (RPS) Predicts Heightened Sensitivity to DNA-Damaging Chemotherapy in Breast Cancer.
|
Academic Article
|
In?Vivo Delivery and Therapeutic Effects of a MicroRNA on Colorectal Liver Metastases.
|
Academic Article
|
Survival outcomes for postoperative chemoradiation in intermediate-risk oral tongue cancers.
|
Academic Article
|
BCL3 expression promotes resistance to alkylating chemotherapy in gliomas.
|
Academic Article
|
Dendritic Cells but Not Macrophages Sense Tumor Mitochondrial DNA for Cross-priming through Signal Regulatory Protein a Signaling.
|
Academic Article
|
Classification for long-term survival in oligometastatic patients treated with ablative radiotherapy: A multi-institutional pooled analysis.
|
Academic Article
|
A phase 1 trial of autologous stem cell transplantation conditioned with melphalan 200?mg/m2 and total marrow irradiation (TMI) in patients with relapsed/refractory multiple myeloma.
|
Academic Article
|
Non-canonical NF-?B Antagonizes STING Sensor-Mediated DNA Sensing in Radiotherapy.
|
Academic Article
|
Molecular Classification of Lymph Node Metastases Subtypes Predict for Survival in Head and Neck Cancer.
|
Academic Article
|
DDX39B interacts with the pattern recognition receptor pathway to inhibit NF-?B and sensitize to alkylating chemotherapy.
|
Academic Article
|
Definition, Biology, and History of Oligometastatic and Oligoprogressive Disease.
|
Academic Article
|
Fecal microbiota transplant rescues mice from human pathogen mediated sepsis by restoring systemic immunity.
|
Academic Article
|
Methodological Development of Combination Drug and Radiotherapy in Basic and Clinical Research.
|
Academic Article
|
Is It Worth It? Consequences of Definitive Head and Neck Reirradiation.
|
Academic Article
|
Coronavirus Disease 2019 Infection Prevention and Control Practices in Wuhan Radiation Therapy.
|
Academic Article
|
(Oligo)metastasis as a Spectrum of Disease.
|
Academic Article
|
Radiotherapy and immunotherapy converge on elimination of tumor-promoting erythroid progenitor cells through adaptive immunity.
|
Academic Article
|
Lactobacillus rhamnosus GG induces cGAS/STING- dependent type I interferon and improves response to immune checkpoint blockade.
|
Academic Article
|
Radiotherapy and Immunotherapy Combinations in the Treatment of Patients with Metastatic Disease: Current Status and Future Focus.
|
Academic Article
|
Phase I Study of Stereotactic Body Radiotherapy plus Nivolumab and Urelumab or Cabiralizumab in Advanced Solid Tumors.
|
Academic Article
|
A Phase 1 Trial of Concurrent or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients With Stage IV NSCLC Study.
|
Academic Article
|
All-trans retinoic acid overcomes solid tumor radioresistance by inducing inflammatory macrophages.
|
Academic Article
|
Phase II Prospective, Open-Label Randomized Controlled Trial Comparing Standard of Care Chemotherapy With and Without Sequential Cytoreductive Interventions for Patients with Oligometastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor Deoxyribose Nucleic Acid (ctDNA) Levels.
|
Academic Article
|
A phase 1 trial utilizing TMI with fludarabine-melphalan in patients with hematologic malignancies undergoing second allo-SCT.
|
Academic Article
|
ASO Visual Abstract: Phase II Prospective Open-Label Randomized Controlled Trial Comparing Standard of Care Chemotherapy with and without Sequential Cytoreductive Interventions for Patients with Oligometastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels.
|
Academic Article
|
A proliferative subtype of colorectal liver metastases exhibits hypersensitivity to cytotoxic chemotherapy.
|